Ah Equity Partners Bio Iii, L.L.C. Eq Rx, Inc. Transaction History
Ah Equity Partners Bio Iii, L.L.C.
- $95 Million
- Q3 2022
A detailed history of Ah Equity Partners Bio Iii, L.L.C. transactions in Eq Rx, Inc. stock. As of the latest transaction made, Ah Equity Partners Bio Iii, L.L.C. holds 19,192,015 shares of EQRX stock, worth $0. This represents 100.0% of its overall portfolio holdings.
Number of Shares
19,192,015
Previous 19,192,015
-0.0%
Holding current value
$0
Previous $90 Million
5.54%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding EQRX
# of Institutions
7Shares Held
67.8MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA17.4MShares$060.15% of portfolio
-
Arboretum Ventures, Inc.13.9MShares$063.96% of portfolio
-
Ah Equity Partners Lsv I, L.L.C. Menlo Park, CA11.4MShares$08.42% of portfolio
-
Ah Equity Partners Lsv Ii, L.L.C. Menlo Park, CA5MShares$011.61% of portfolio
-
Beaumont Financial Partners, LLC731KShares$00.35% of portfolio
About EQRx, Inc.
- Ticker EQRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 448,140,992
- Description
- EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...